CN101203756B - 改进的免疫测定方法 - Google Patents

改进的免疫测定方法 Download PDF

Info

Publication number
CN101203756B
CN101203756B CN200680018335.XA CN200680018335A CN101203756B CN 101203756 B CN101203756 B CN 101203756B CN 200680018335 A CN200680018335 A CN 200680018335A CN 101203756 B CN101203756 B CN 101203756B
Authority
CN
China
Prior art keywords
antigen
antibody
patient
purposes
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN200680018335.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101203756A (zh
Inventor
约翰·福赛思·鲁塞尔·罗伯特森
托尼·巴尔内斯
安德烈亚·默里
卡罗琳·查普曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Furim Co ltd
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of CN101203756A publication Critical patent/CN101203756A/zh
Application granted granted Critical
Publication of CN101203756B publication Critical patent/CN101203756B/zh
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN200680018335.XA 2005-05-27 2006-05-26 改进的免疫测定方法 Active CN101203756B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68542205P 2005-05-27 2005-05-27
GB0510943.4 2005-05-27
GB0510943A GB2426581A (en) 2005-05-27 2005-05-27 Immunoassay methods
US60/685,422 2005-05-27
PCT/GB2006/001944 WO2006126008A2 (en) 2005-05-27 2006-05-26 Improved immunoassay methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201210248279.6A Division CN102749447B (zh) 2005-05-27 2006-05-26 改进的免疫测定方法

Publications (2)

Publication Number Publication Date
CN101203756A CN101203756A (zh) 2008-06-18
CN101203756B true CN101203756B (zh) 2016-03-09

Family

ID=34834805

Family Applications (2)

Application Number Title Priority Date Filing Date
CN200680018335.XA Active CN101203756B (zh) 2005-05-27 2006-05-26 改进的免疫测定方法
CN201210248279.6A Active CN102749447B (zh) 2005-05-27 2006-05-26 改进的免疫测定方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201210248279.6A Active CN102749447B (zh) 2005-05-27 2006-05-26 改进的免疫测定方法

Country Status (19)

Country Link
US (1) US8722339B2 (https=)
EP (3) EP1889059B1 (https=)
JP (1) JP4876127B2 (https=)
KR (1) KR101400986B1 (https=)
CN (2) CN101203756B (https=)
AT (2) ATE554386T1 (https=)
AU (1) AU2006250923B2 (https=)
CA (1) CA2609793C (https=)
DE (1) DE602006007703D1 (https=)
DK (3) DK2073008T3 (https=)
ES (3) ES2328171T3 (https=)
GB (1) GB2426581A (https=)
MX (1) MX2007014815A (https=)
NO (1) NO339224B1 (https=)
PL (2) PL1889059T3 (https=)
PT (2) PT2073008E (https=)
RU (1) RU2416095C2 (https=)
SI (1) SI2073008T1 (https=)
WO (1) WO2006126008A2 (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
GB9810040D0 (en) 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
GB2395270B (en) 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
US7858323B2 (en) 2004-06-09 2010-12-28 The Regents Of The University Of Michigan Phage microarray profiling of the humoral response to disease
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
SI1889059T1 (sl) 2005-05-27 2009-12-31 Oncimmune Ltd Izboljšani imunotestni postopek
US20070178504A1 (en) * 2005-12-22 2007-08-02 Tracey Colpitts Methods and marker combinations for screening for predisposition to lung cancer
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
CA2646329C (en) 2006-03-20 2018-07-03 The Regents Of The University Of California Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
JP5495159B2 (ja) * 2006-09-13 2014-05-21 オンクイミューン リミテッド 改善されたイムノアッセイ法
AU2007305166A1 (en) * 2006-10-03 2008-04-10 University Of Southern California GRP78 as a predictor of responsiveness to therapeutic agents
EP2126562B1 (en) * 2007-02-23 2014-12-31 Physicians Choice Laboratory Services, LLC Clinical intervention directed diagnostic methods
WO2009032949A2 (en) 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
JP5615181B2 (ja) 2007-11-27 2014-10-29 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 関節炎の予防及び治療のための組成物及び方法
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
CN103884840A (zh) * 2008-02-21 2014-06-25 艾瑞斯国际有限公司 早期确定前列腺癌治疗后复发的方法
CN102216772B (zh) * 2008-09-19 2014-11-26 里奇维尤诊断公司 用于固体生物对象的分析的方法
WO2010085548A2 (en) * 2009-01-22 2010-07-29 Li-Cor, Inc. Single molecule proteomics with dynamic probes
ES2712732T3 (es) 2009-02-17 2019-05-14 Cornell Res Foundation Inc Métodos y kits para el diagnóstico de cáncer y la predicción de valor terapéutico
WO2010102412A1 (en) * 2009-03-11 2010-09-16 Augurex Life Sciences Corporation Compositions and methods for characterizing arthritic conditions
AU2010264067A1 (en) * 2009-06-23 2012-01-19 Eventus Diagnostics Israel Ltd. A method and system for the detection of cancer
CN101762700A (zh) * 2009-06-24 2010-06-30 北京科美东雅生物技术有限公司 一种定量检测血液中癌胚抗原的磁性免疫层析试纸条及制备方法
WO2011011688A2 (en) * 2009-07-24 2011-01-27 Rhode Island Hospital DENDRITIC CELL VACCINES FOR ASPARAGINYL- β - HYDROXYLASE EXPRESSING TUMORS
JP5697677B2 (ja) * 2009-10-26 2015-04-08 ネステク ソシエテ アノニム 抗ｔｎｆ薬及び自己抗体の検出用アッセイ
AU2010325969B2 (en) 2009-12-02 2016-10-20 Imaginab, Inc. J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen
US20110237461A1 (en) 2010-03-17 2011-09-29 The Regents Of The University Of Michigan Using phage epitopes to profile the immune response
CN102884434B (zh) 2010-05-12 2015-08-19 希尔氏宠物营养品公司 用于诊断、控制和预防犬科动物炎症及减轻犬科动物炎性病况的方法
US20130310266A1 (en) * 2010-09-03 2013-11-21 Immport Therapeutics, Inc. Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
CA2814029C (en) * 2010-10-08 2017-05-09 Shanghai Kexin Biotech Co., Ltd. Moesin fragments associated with immune thrombocytopenia
EA018848B1 (ru) * 2010-10-20 2013-11-29 Вадим Юльевич ШАНИН Иммунологически активное вещество, способ его получения, биозонд на его основе и способ диагностики состояния здоровья с применением биозонда, фармацевтическая композиция и способ лечения с использованием фармацевтической композиции
CN102125698A (zh) * 2010-11-29 2011-07-20 昆明理工大学 具有正常免疫功能的小鼠移植肿瘤模型的建立方法
EP2726867B1 (en) * 2011-07-01 2016-04-06 Inova Diagnostics, Inc. Method for increasing specificity of diagnostic tests for autoimmune diseases
PT2768851T (pt) 2011-10-21 2017-09-08 Augurex Life Sciences Corp Antigénios derivados de 14-3-3 citrulinada e utilizações dos mesmos no diagnóstico de artrite reumatoide
CN102590530B (zh) * 2012-03-02 2014-06-25 常晓天 Krt84自我免疫抗体作为诊断、检测类风湿性关节炎的诊断标记物的应用
WO2013163269A1 (en) * 2012-04-24 2013-10-31 Sri International Human serum biomarkers of prostate cancer and sars-cov
JP2016507748A (ja) * 2013-01-31 2016-03-10 アリゾナ ボード オブ リージェンツ， ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ， アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー 卵巣癌の早期発見のための自己抗体サイン
CN103604923B (zh) * 2013-10-22 2015-05-13 卫生部北京医院 检测抗甲状腺过氧化物酶和甲状腺球蛋白的天然双特异性抗体的试剂盒
AU2015215008B2 (en) * 2014-02-05 2019-11-28 Fujirebio Diagnostics Ab Composition and method for detecting malignant neoplastic disease
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
CN104356226B (zh) * 2014-11-04 2017-03-29 青岛海兰深生物科技有限公司 一种检测血浆免疫标志物‑vegfr1自身抗体的抗原多肽及应用
US11254744B2 (en) 2015-08-07 2022-02-22 Imaginab, Inc. Antigen binding constructs to target molecules
CN113848322A (zh) * 2015-12-11 2021-12-28 善福德健康 用于监测乳腺癌治疗的试剂和方法
CN106053812B (zh) * 2016-06-29 2017-12-08 厦门生迪生物技术有限公司 一种用于肝癌早期筛查和诊断的多种自身抗体联合检测elisa试剂盒
JP6334017B1 (ja) * 2017-01-25 2018-05-30 ファナック株式会社 誘導電動機の制御装置
US11266745B2 (en) 2017-02-08 2022-03-08 Imaginab, Inc. Extension sequences for diabodies
WO2018234577A1 (en) * 2017-06-23 2018-12-27 Protagen Ag IMMUNO-ONCOLOGY FOR THE TREATMENT OF CANCER
WO2019152498A1 (en) * 2018-02-01 2019-08-08 Sedia Biosciences Corporation A rapid quantitative assay to assess duration of infection
SG10201908922UA (en) * 2019-09-25 2021-04-29 Sengenics Corp Pte Ltd Identification of health status in the elderly using immunological biomarkers
JP7744641B2 (ja) 2020-07-14 2025-09-26 フリーノム リミテッド 肺癌における自己抗体を検出するための抗原の組合せの使用
GB2600701A (en) 2020-11-04 2022-05-11 Oncimmune Ltd Antibody assay
CN112345755B (zh) * 2020-09-23 2023-06-16 杭州凯保罗生物科技有限公司 乳腺癌的生物标志物及其应用
KR102540416B1 (ko) * 2021-04-09 2023-06-12 주식회사 애티스랩 암 진단용 조성물, 키트, 및 이를 이용한 암 진단 방법
GB2622246A (en) 2022-09-08 2024-03-13 Oncimmune Germany Gmbh Antibody assay

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒
CN1585900A (zh) * 2001-11-28 2005-02-23 Rsr有限公司 检测与胰腺胰岛细胞抗原分子和/或胰岛素反应的自身抗体

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ211453A (en) * 1984-03-22 1989-01-06 Biotechnology Research Enterpr Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides
EP0236606B1 (en) 1986-03-10 1992-06-24 Imre Corporation Immune complex assay
US4925788A (en) * 1986-10-24 1990-05-15 Immunicon Corporation Immunoassay system and procedure based on precipitin-like interaction between immune complex and Clq or other non-immunospecific factor
AU2253688A (en) 1987-07-24 1989-03-01 Xoma Corporation Methods for breast cancer detection
US4937185A (en) * 1987-07-31 1990-06-26 The Ohio State University Research Foundation Detection of circulating antibodies to a cancer marker protein
US7282345B1 (en) * 1989-08-04 2007-10-16 Schering Ag C-erbB-2 external domain: GP75
US5157020A (en) * 1990-05-24 1992-10-20 Research Corporation Tech., Inc. Synthetic senescent cell antigen
DK9091D0 (da) 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
DE4120412C1 (https=) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De
US6280962B1 (en) * 1991-11-25 2001-08-28 Yoreh Biotechnologies Ltd. Whole blood/mitogen assay for the early detection of a subject with cancer and kit
US6322989B1 (en) * 1991-11-25 2001-11-27 Yoreh Biotechnologies, Ltd. Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
PT1024191E (pt) 1991-12-02 2008-12-22 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
CA2118015A1 (en) * 1992-04-14 1993-10-28 Jeffrey R. Marks Method of detecting tumors containing complexes of p53 and hsp70
US5801005A (en) * 1993-03-17 1998-09-01 University Of Washington Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
US5763164A (en) 1993-04-16 1998-06-09 Northwestern University Immunogenic cancer proteins and peptides and methods of use
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
US5721105A (en) * 1994-02-20 1998-02-24 B.R.A.H.M.S. Diagnostica Gmbh Method for the immunological determination of proteins and kit for carrying out the method
JPH07294530A (ja) * 1994-04-20 1995-11-10 Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk 病原体に対する体液中の抗体検出法
CA2148971A1 (en) 1994-05-26 1995-11-27 Izak Bahar Calibrator matrix
WO1996000084A1 (en) 1994-06-24 1996-01-04 Torchilin Vladimir P Use of autoantibodies for tumor therapy and prophylaxis
IL110464A0 (en) 1994-07-26 1994-10-21 Univ Ramot Novel proteins for the diagnosis, imaging, and therapy of human cancer
US5561049A (en) * 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPN568095A0 (en) 1995-09-27 1995-10-26 Austin Research Institute, The Anti-Galalpha(1,3)Gal antibody binding peptides
GB9521544D0 (en) 1995-10-20 1995-12-20 Univ Dundee Activation of P53 protein and therapeutic applications thereof
JPH09189702A (ja) 1996-01-09 1997-07-22 Hitachi Chem Co Ltd 抗ムチン抗体の測定法、癌の測定法及び癌診断薬
ATE283069T1 (de) * 1996-08-16 2004-12-15 Univ Johns Hopkins Med Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung
CN1044092C (zh) * 1997-02-26 1999-07-14 上海医科大学 抗原－抗体－重组dna复合型疫苗
EP1019727A1 (en) 1997-06-03 2000-07-19 Amdl, Inc Immunoassay for the detection of cancer
DE19805815C1 (de) * 1998-02-13 1999-11-11 Ansgar W Lohse Diagnostikum zum Erkennen der autoimmunen Hepatitis
JP4083855B2 (ja) 1998-02-16 2008-04-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 肺癌予後検査方法
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
AUPP349098A0 (en) 1998-05-13 1998-06-04 South Eastern Sydney Area Health Service A method of monitoring pancreatic tissue viability
WO2000026668A2 (en) 1998-11-05 2000-05-11 The Regents Of The University Of Michigan S100 proteins and autoantibodies as serum markers for cancer
US6387639B1 (en) * 1998-11-10 2002-05-14 Sloan-Kettering Institute For Cancer Research Ma family polypeptides and anti-Ma antibodies
GB9827228D0 (en) 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US7807810B2 (en) * 1999-04-08 2010-10-05 The Ohio State University Research Foundation Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20020064801A1 (en) * 1999-12-01 2002-05-30 Ryan Jeffrey R. Novel and practical serological assay for the clinical diagnosis of leishmaniasis
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US20030138860A1 (en) * 2000-06-14 2003-07-24 Robertson John Forsyth Russell Cancer detection methods and reagents
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
US20020137097A1 (en) 2000-12-13 2002-09-26 Bio-Rad Laboratories, Inc. Standard diluent for multiplex assays
US7745141B2 (en) * 2001-06-21 2010-06-29 New York University Mycobacterial proteins as early antigens for serodiagnosis and vaccines
US20030049692A1 (en) * 2002-09-16 2003-03-13 Norman Latov Detection of anti-glycolipid antibodies by latex agglutination assay
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
JP2005352771A (ja) * 2004-06-10 2005-12-22 Hitachi Software Eng Co Ltd 発現プロファイルによるパターン認識システム
US20060141547A1 (en) * 2004-11-16 2006-06-29 Das Hasi R Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis
GB2426581A (en) 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
EP1789435B1 (en) * 2005-09-12 2010-02-24 Industry Foundation of Chonnam National University A method for production of mature natural killer cell
TWI304443B (en) * 2005-12-30 2008-12-21 Nat Health Research Institutes Alpha-enolase specific antibody and method of use
CN101632020B (zh) * 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
JP5495159B2 (ja) 2006-09-13 2014-05-21 オンクイミューン リミテッド 改善されたイムノアッセイ法
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097252A (zh) * 1993-07-03 1995-01-11 首钢总公司 多元同步标记分析法
CN1585900A (zh) * 2001-11-28 2005-02-23 Rsr有限公司 检测与胰腺胰岛细胞抗原分子和/或胰岛素反应的自身抗体
CN1547025A (zh) * 2003-12-03 2004-11-17 刘春杰 高灵敏度酶联免疫分析检测试剂盒

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jian-Ying Zhang et al.Enhancement of Antibody Detection in Cancer Using Panel of Recombinant Tumor-associated Antigens.《Cancer Epidemiol Biomarkers Prev》.2003,136-143. *
Julie Paré et al.An enzyme-linked immunosorbent assay (ELISA) for serological diagnosis of Neospora sp. infection in cattle.《J Vet Diagn Invest》.1995,352-359. *

Also Published As

Publication number Publication date
CN101203756A (zh) 2008-06-18
EP1889059A2 (en) 2008-02-20
EP1889059B1 (en) 2009-07-08
EP2275815A3 (en) 2011-02-02
EP2275815A2 (en) 2011-01-19
EP2073008A1 (en) 2009-06-24
AU2006250923A1 (en) 2006-11-30
DK2275815T3 (da) 2014-05-12
KR101400986B1 (ko) 2014-05-28
MX2007014815A (es) 2008-04-11
DE602006007703D1 (de) 2009-08-20
PL1889059T3 (pl) 2009-12-31
WO2006126008A2 (en) 2006-11-30
KR20080034851A (ko) 2008-04-22
WO2006126008A3 (en) 2007-03-29
US8722339B2 (en) 2014-05-13
ES2384935T3 (es) 2012-07-16
PT2073008E (pt) 2012-06-18
AU2006250923B2 (en) 2012-06-07
ES2458105T3 (es) 2014-04-29
NO20076656L (no) 2008-02-26
CN102749447B (zh) 2015-05-13
CA2609793C (en) 2018-05-22
RU2007149281A (ru) 2009-07-10
NO339224B1 (no) 2016-11-21
DK2073008T3 (da) 2012-06-04
EP2073008B1 (en) 2012-04-18
SI2073008T1 (sl) 2012-08-31
US20080305476A1 (en) 2008-12-11
ATE436018T1 (de) 2009-07-15
JP4876127B2 (ja) 2012-02-15
PL2073008T3 (pl) 2012-09-28
ES2328171T3 (es) 2009-11-10
EP2275815B1 (en) 2014-04-02
PT2275815E (pt) 2014-07-10
GB0510943D0 (en) 2005-07-06
DK1889059T3 (da) 2009-11-02
ATE554386T1 (de) 2012-05-15
RU2416095C2 (ru) 2011-04-10
CN102749447A (zh) 2012-10-24
CA2609793A1 (en) 2006-11-30
JP2008542703A (ja) 2008-11-27
GB2426581A (en) 2006-11-29

Similar Documents

Publication Publication Date Title
CN101203756B (zh) 改进的免疫测定方法
CN101632020B (zh) 改进的免疫测定方法
JP5736598B2 (ja) 改善されたイムノアッセイ法
CN106662586A (zh) 改进的免疫测定方法
US9719984B2 (en) Immunoassay methods
CN103257227B (zh) 改进的免疫测定方法
AU2012209004B2 (en) Improved immunoassay methods
HK1152565B (en) Improved immunoassay methods
HK1152565A (en) Improved immunoassay methods

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: Nottingham, England

Patentee after: Furim Co.,Ltd.

Country or region after: Britain

Address before: Nottingham, England

Patentee before: ONCIMMUNE Ltd.

Country or region before: Britain